16 September 2022 : Review article
A Review of Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination Following Solid Organ Transplantation
Ilona Cieślak1ABCDEF, Magdalena Kwapisz2AEF*, Olga Tronina3ABCDEF, Joanna Gotlib1ABCDEF, Wojciech Lisik2ABCDEF, Dariusz Wasiak4ABCDEF, Marta Hreńczuk4ABCDEF, Mansur Rahnama5BDEF, Piotr Małkowski4ABCDEFDOI: 10.12659/AOT.936949
Ann Transplant 2022; 27:e936949
Table 1 Seropositive immune response for 2 doses of mRNA SARS-CoV-2 vaccine (%).
| Author of the study | Kidney transplant recipients (%) | Liver transplant recipients (%) | Heart transplant recipients (%) | Lung transplant recipients (%) | Pancreas ± kidney transplant recipients (%) | Haemodialysis patients (%) | Cirrhotic patients (%) |
|---|---|---|---|---|---|---|---|
| Marinaki []21 | 20 | – | 75 | ||||
| Boyarski []28 | 48 | 80 | 56 | 39 | 20 | ||
| Grupper []29 | 37.5 | ||||||
| Shostak []30 | 60 | ||||||
| Hall []32 | 28.5 | 72.7 | 12.5 | 41.4 | 38.9 | ||
| Ruether []33 | 36.6 | 65.4 | |||||
| Crespo []34 | 77.6 | ||||||
| Bertrand []37 | 17.8 | 88.9 | |||||
| Thuluvath []38 | 38.7 | 76 | |||||
| Narasimhan []55 | 25 | ||||||
| Nazaruk []57 | 88.9 | ||||||
| Rabinowich []59 | 47.5 |